Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes.

Vittorio UnferMichele RussoCesare AragonaGabriele BilottaMario Montanino OlivaMariano Bizzarri

Published in: Biomedicines (2023)

Subjects selected for the study exhibited a differential response to myo-Ins therapy according to their PCOS phenotypes. The data suggest that the same treatment might not equally improve the parameters of the PCOS condition in each sub-group of patients. It is crucial to distinguish the various phenotypes to properly select the therapeutical approach.

Keyphrases

polycystic ovary syndrome
end stage renal disease
ejection fraction
peritoneal dialysis
prognostic factors
electronic health record
combination therapy
insulin resistance
metabolic syndrome
adipose tissue